AI assistant
CME GROUP INC. — Director's Dealing 2022
Mar 17, 2022
29871_dirs_2022-03-17_5dca20fd-262d-41f9-b7a8-c399c446912e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2022-03-15
Reporting Person: McCourt Timothy Francis (Sr MD Global Head Equity & FX)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-03-15 | Common Stock Class A | A | 202 | $232 | Acquired | 2478 | Direct |
| 2022-03-15 | Common Stock Class A | F | 73 | $232 | Disposed | 2405 | Direct |
| 2022-03-15 | Common Stock Class A | A | 1044 | $232 | Acquired | 3449 | Direct |
Footnotes
F1: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021.
F2: Mr. McCourt surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award.
F3: On March 15, 2022, the reporting person was granted restricted shares, vesting in four equal annual installments on the first four anniversaries of the grant date, subject to the restricted share agreement.